Britain is ‘a terrible place’ to sell medicines, says drug firm executive
The article highlights the concerns raised by a senior executive from the pharmaceutical company Sanofi regarding the challenges of selling medicines in the UK. According to Paul Naish, the UK head of market access for Sanofi, Britain is "a terrible place" to sell drugs and is "not a good place" to develop or sell new treatments. Naish has urged the UK government to come up with a "proper" roadmap to increase spending on new medicines, stating that the country is "at a critical point." The article suggests that the pharmaceutical industry is facing difficulties in the British market, which may have implications for the development and availability of new treatments for patients.
Source: For the complete article, please visit the original source link below.
